Physician profile
Jonathan Y Ting
NPI 1609034651
$2,756.57
in general payments reported to CMS, 2019-2025
12 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2021: $330 · 2022: $421 · 2023: $38.59 · 2024: $1,433 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $987 · Food and Beverage: $805.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $987.22 |
| Food and Beverage | $805.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,508.35 | 2021-2024 | Fusion |
| Regeneron Healthcare Solutions, INC. | $384.13 | 2021-2022 | |
| Stryker Corporation | $215.37 | 2021-2025 | Core |
| Optinose US, INC. | $149.78 | 2019 | |
| Leica Microsystems INC. | $112.67 | 2025 | |
| Integra Lifesciences Corporation | $110.12 | 2024 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Cook Biotech Incorporated | $100.30 | 2022 | |
| Acclarent, INC | $49.12 | 2019 | |
| Gilead Sciences, INC. | $43.02 | 2022 | |
| Depuy Synthes Sales INC. | $38.59 | 2023 | Matrixmandible, Trumatch |
| Astrazeneca Pharmaceuticals Lp | $30.90 | 2025 | |
| Olympus America INC. | $14.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Ting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.